DAVOS, Switzerland  – The World Health Organization (WHO) has announced plans to set up a new TB Vaccine Accelerator Council to increase momentum for the development of a vaccine to combat the world’s most deadly infectious disease. Speaking at a high-level panel at the World Economic Forum’s Annual Meeting where the plan was launched, WHO […] Continue reading ->
In the wake of the COVID pandemic, the US National Institutes of Health (NIH) and Israel’s largest medical center, Sheba Medical Center, are launching a scientific collaboration aimed at identifying emerging disease threats in the region. One of the first projects planned will be a study examining the impacts on antibody defenses amongst travelers from […] Continue reading ->
Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need.  The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading ->
COVID-19, conflicts and climate change are posing additional challenges to efforts to achieve universal health coverage (UHC) in the Eastern Mediterranean region (EMRO), the World Health Organization (WHO) acknowledged on the eve of Universal Health Coverage (UHC) Day on Monday. “The COVID-19 pandemic demonstrated the vulnerability of our health, social protection and economic systems,”  Dr […] Continue reading ->
Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance.  Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading ->
Gavi, the Vaccine Alliance, has pushed back on media reports that its board has decided to end COVID vaccine support for 37 middle-income countries next year – and end altogether the dedicated COVAX vaccine facility, supplying free vaccines to some 92 low- and middle-income countries, in 2024. A high-ranking official at Gavi told Health Policy […] Continue reading ->